Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (sportif iii): randomised controlled trial

2004 ◽  
Vol 13 (3) ◽  
pp. 63
Sign in / Sign up

Export Citation Format

Share Document